Stem cell therapy for complex perianal fistulas in Crohn’s disease patients
https://doi.org/10.31146/1682-8658-ecg-246-2-84-88
Abstract
About the Authors
Z. M. AbdulatipovaRussian Federation
O. V. Knyazev
Russian Federation
M. A. Danilov
Russian Federation
G. A. Krotov
Russian Federation
References
1. Konoplyannikov M.А., Knyazev O.V., Baklaushev V.P. MSC Therapy for Inflammatory Bowel Disease. Journal of Clinical Practice. 2021;12(1):53-65. doi: 10.17816/clinpract64530.@@ Коноплянников М.А., Князев О.В., Баклаушев В.П. Применение МСК для терапии воспалительных заболеваний кишечника. Клиническая практика. 2021;12(1):53-65. doi: 10.17816/clinpract64530.
2. Anosov I.S., Eryshova T.A., Khryukin R.Yu., Zakharov M.A., Achkasov S.I. Mesenchymal stem cells for perianal fistulizing Crohn’s disease (systematic review and meta-analysis). Koloproktologia. 2024;23(3):100-111. doi: 10.33878/2073-7556-2024-23-3-100-111.@@ Аносов И.С., Ерышова Т.А., Хрюкин Р.Ю., Захаров М.А., Ачкасов С.И. Мезенхимальные стволовые клетки в лечении свищей перианальной области при болезни Крона (систематический обзор литературы и метаанализ). Колопроктология. 2024;23(3):100-111. doi: 10.33878/2073-7556-2024-23-3-100-111.
3. Bedzhanyan A.L., Eremin I.I., Bumbazhay A.A. et al. Treatment of perianal fistula in Crohn’s disease with autologous adipose tissue derived regenerative cells. Clinical and Experimental Surgery. Petrovsky Journal. 2024; 12 (4): 43-50. (in Russ.) doi: 10.33029/2308-1198-2024-12-4-43-50.@@ Беджанян А.Л., Еремин И.И., Бумбажай А.А. и др. Лечение перианального свища при болезни Крона аутологичными регенеративными клетками жировой ткани. Клиническая и экспериментальная хирургия. 2024; 12 (4): 43-50. doi: 10.33029/2308-1198-2024-12-4-43-50
4. Barbosa J. C. C. et al. Safety and efficacy of mesenchymal stem cell therapy in adults with inflammatory bowel disease: a systematic review of randomized controlled trials. Cytotherapy. 2025;27(5): S51. doi: 10.1016/j.jcyt.2025.03.084.
5. Sørensen K.M. et al. Treatment of fistulizing perianal crohn’s disease by autologous microfat enriched with adipose-derived regenerative cells. Inflammatory Bowel Diseases. 2022;28(6):967-970. doi: 10.1093/ibd/izab276.
6. Anosov I.S., Eryshova T.A., Khryukin R. Yu., Zakharov M.A., Achkasov S.I. Mesenchymal stem cells for perianal fistulizing Crohn’s disease (systematic review and meta-analysis). Koloproktologia. 2024;23(3):100-111. doi: 10.33878/2073-7556-2024-23-3-100-111.@@ Аносов И.С., Ерышова Т.А., Хрюкин Р.Ю., Захаров М.А., Ачкасов С.И. Мезенхимальные стволовые клетки в лечении свищей перианальной области при болезни Крона (систематический обзор литературы и метаанализ). Колопроктология. 2024;23(3):100-111. doi: 10.33878/2073-7556-2024-23-3-100-111.
7. Hadizadeh A. et al. Localized Administration of Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Refractory Perianal Fistula in Patients With Crohn’s Disease: A Phase II Clinical Trial. Diseases of the Colon & Rectum. 2024;67(12):1564-1575. doi: 10.1097/DCR.0000000000003502.
8. Wei S. et al. Mesenchymal stromal cells: new generation treatment of inflammatory bowel disease. Journal of Inflammation Research. 2024: 3307-3334. doi: 10.2147/JIR.S458103.
9. White I. et al. Mesenchymal stem cell therapy for Crohn’s perianal fistula - a real-world experience. Colorectal Disease. 2024;26(1):102-109. doi: 10.1111/codi.16830.
10. Bacsur P. et al. Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn’s Disease: An International Real-Life Retrospective Multicentre Cohort Study. Alimentary Pharmacology & Therapeutics. 2025;61(2):335-345. doi: 10.1111/apt.18359.
11. Arkenbosch J.H.C., van Ruler O., Dwarkasing R.S. et al. Platelet-Rich Stroma from Crohn’s disease patients for treatment of perianal fistula shows a higher myeloid cell profile compared to non-IBD controls. Stem Cell Research. 2023. doi: 10.1016/j.scr.2023.103039.
12. Arkenbosch J.H.C. et al. Stromal vascular fraction with platelet-rich plasma injection during surgery is feasible and safe in treatment-refractory perianal fistulising Crohn’s disease: A pilot study. Alimentary Pharmacology & Therapeutics. 2023;57(7):783-791. doi: 10.1111/apt.17347.
13. Dozois E.J. et al. Durable response in patients with refractory fistulizing perianal Crohn’s disease using autologous mesenchymal stem cells on a dissolvable matrix: results from the phase I stem cell on matrix plug trial. Diseases of the Colon & Rectum. 2023;66(2):243-252. doi: 10.1097/DCR.0000000000002579.
14. Alonso-Gomez M. et al. Real-life effectiveness of allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulizing refractory Crohn’s disease. Clinics and Research in Hepatology and Gastroenterology. 2024;48(9):102473. doi: 10.1016/j.clinre.2024.102473.
15. Serrero M., Grimaud F. et al. Long-term safety and efficacy of local microinjection of autologous ADSVF and microfat for perianal Crohn’s fistula. Gastroenterology. 2019. doi: 10.1007/s10151-025-03138-y.
16. Guillo L., Grimaud F. et al. Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn’s disease. Stem Cell Research & Therapy. 2022. doi: 10.1186/s13287-022-02738-x.
17. Aldakhil M., Albarrak R.I., Alomar J.A. et al. The efficacy of adipose-derived stem cell therapy for complex perianal fistulas in Crohn’s disease patients: a systematic review. Surg Open Sci. 2025. doi: 10.1016/j.sopen.2025.11.002.
18. Alonso-Gomez M. et al. Real-life effectiveness of allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulizing refractory Crohn’s disease. Clinics and Research in Hepatology and Gastroenterology. 2024;48(9):102473. doi: 10.1016/j.clinre.2024.102473.
19. Potenza A.E. et al. Effectiveness of autologous emulsified stromal vascular fraction tissue injection for the treatment of complex perianal fistulas in inflammatory bowel diseases patients: a pilot study. Therapeutic Advances in Gastroenterology. 2024;(17):17562848241263014. doi: 10.1177/17562848241263014.
20. Laureti S. et al. Autologous microfragmented adipose tissue injection in refractory complex Crohn’s perianal fistulas: long-term results at 6.7 years mean follow-up. Inflammatory bowel diseases. 2025;31(7):1943-1951. doi: 10.1093/ibd/izae283
21. Arkenbosch J.H.C., van Ruler O., Dwarkasing R.S. et al. Platelet-Rich Stroma from Crohn’s disease patients for treatment of perianal fistula shows a higher myeloid cell profile compared to non-IBD controls. Stem Cell Research. 2023. doi: 10.1016/j.scr.2023.103039.
22. Cao Y. et al. Efficacy of stem cells therapy for Crohn’s fistula: a meta-analysis and systematic review. Stem cell research & therapy. 2021;12(1):32. doi: 10.1186/s13287-020-02095-7.
23. Colombo F. et al. Stem cell injection for complex refractory perianal fistulas in Crohn’s disease: a single center initial experience. Frontiers in Surgery. 2022;9:834870. doi: 10.3389/fsurg.2022.834870.
24. Arkenbosch J. H. C. et al. Stromal vascular fraction with platelet-rich plasma injection during surgery is feasible and safe in treatment-refractory perianal fistulising Crohn’s disease: A pilot study. Alimentary Pharmacology & Therapeutics. 2023;57(7):783-791. doi: 10.1111/apt.17347.
Review
For citations:
Abdulatipova Z.M., Knyazev O.V., Danilov M.A., Krotov G.A. Stem cell therapy for complex perianal fistulas in Crohn’s disease patients. Experimental and Clinical Gastroenterology. 2026;(2):84-88. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-246-2-84-88
JATS XML





































